ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,039.31
      -0.47%
      US Tech 100
      20,882.00
      0.05%
      Dow Jones
      44,713.52
      -0.31%
      Brent Oil
      75.565
      -0.47%
      Bitcoin
      105,245.81
      1.45%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Dyne Therapeutics Inc (DYN) Quote

      Dyne Therapeutics Inc

      Dyne Therapeutics Inc (DYN)

      NASDAQ
      13.54
      0.08
      (0.59%)
      Closed January 30 4:00PM
      Delayed by 15 minutes
      13.54
      0.03
      (0.22%)
      After Hours: 5:52PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      13.54
      Bid
      13.43
      Ask
      14.09
      Volume
      1,278,286
      13.33 Day's Range 13.97
      13.235 52 Week Range 47.45
      Market Cap
      1.378B
      Previous Close
      13.46
      Open
      13.40
      Last Trade
      10
      @
      13.98
      Last Trade Time
      Financial Volume
      $ 17,397,681
      VWAP
      13.6102
      Average Volume (3m)
      1,656,329
      Shares Outstanding
      101,765,958
      Dividend Yield
      -
      PE Ratio
      -5.83
      Earnings Per Share (EPS)
      -2.32
      Revenue
      -
      Net Profit
      -235.94M

      About Dyne Therapeutics Inc

      Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.dyne-tx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was $13.46. Over the last year, Dyne Therapeutics shares have traded in a share price range of $ 13.235 to $ 47.45.

      Dyne Therapeutics currently has 101,765,958 shares outstanding. The market capitalization of Dyne Therapeutics is $1.37 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -5.83.

      Ask ADVFN Intelligence (AI)

      DYN Latest News

      More News

      Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

      - Company Anticipates Submitting for U.S. Accelerated Approval in H1 2026 - WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage...

      January 21 2025
      GlobeNewswire Inc.

      Form 8-K - Current report

      January 10 2025
      Edgar (US Regulatory)

      Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101

      - DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and...

      January 10 2025
      GlobeNewswire Inc.

      Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

      WALTHAM, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

      January 09 2025
      GlobeNewswire Inc.

      Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

      WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...

      January 08 2025
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 06 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.02-7.0054945054914.5614.6513.235535250013.72466991CS
      4-10.33-43.276078759923.8726.2213.235325234215.52896329CS
      12-16.38-54.745989304829.9235.6813.235165632920.9232791CS
      26-31.16-69.709172259544.747.4513.235140061028.22372412CS
      52-7.26-34.903846153820.847.4513.235133099028.7324724CS
      1566.5292.87749287757.0247.454.377276321.90545444CS
      260-9.91-42.260127931823.4547.454.362091621.29013785CS

      DYN - Frequently Asked Questions (FAQ)

      What is the current Dyne Therapeutics share price?
      The current share price of Dyne Therapeutics is $ 13.54
      How many Dyne Therapeutics shares are in issue?
      Dyne Therapeutics has 101,765,958 shares in issue
      What is the market cap of Dyne Therapeutics?
      The market capitalisation of Dyne Therapeutics is USD 1.37B
      What is the 1 year trading range for Dyne Therapeutics share price?
      Dyne Therapeutics has traded in the range of $ 13.235 to $ 47.45 during the past year
      What is the PE ratio of Dyne Therapeutics?
      The price to earnings ratio of Dyne Therapeutics is -5.83
      What is the reporting currency for Dyne Therapeutics?
      Dyne Therapeutics reports financial results in USD
      What is the latest annual profit for Dyne Therapeutics?
      The latest annual profit of Dyne Therapeutics is USD -235.94M
      What is the registered address of Dyne Therapeutics?
      The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Dyne Therapeutics website address?
      The website address for Dyne Therapeutics is www.dyne-tx.com
      Which industry sector does Dyne Therapeutics operate in?
      Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DGNXDiginex Ltd
      $ 49.18
      (228.09%)
      		3.34M
      SLXNSilexion Therapeutics Corporation
      $ 3.1301
      (131.86%)
      		330.45M
      KRKR36Kr Holdings Inc
      $ 9.10
      (114.12%)
      		23.61M
      SPGCSacks Parente Golf Inc
      $ 0.6001
      (57.92%)
      		52.17M
      XFORX4 Pharmaceuticals Inc
      $ 0.7542
      (56.54%)
      		42.5M
      ZKINZK International Group Co Ltd
      $ 0.4813
      (-41.21%)
      		3.1M
      MGOLMGO Global Inc
      $ 0.1019
      (-38.73%)
      		70.52M
      BACKIMAC Holdings Inc
      $ 0.7869
      (-35.50%)
      		2.37M
      EYENEyenovia Inc
      $ 0.03695
      (-35.18%)
      		25.31M
      HAOHaoxi Health Technology Ltd
      $ 2.52
      (-31.89%)
      		484.94k
      NVDANVIDIA Corporation
      $ 123.70
      (-4.10%)
      		466.94M
      SLXNSilexion Therapeutics Corporation
      $ 3.1301
      (131.86%)
      		330.45M
      OCEAOcean Biomedical Inc
      $ 0.249929
      (-24.26%)
      		186.52M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.428
      (-6.98%)
      		148.12M
      RIMEAlgorhythm Holdings Inc
      $ 0.0259
      (-16.18%)
      		138.96M

      Discussion

      View Full Feed
      ron_66271 ron_66271 10 minutes ago
      CTS are in the Same Camp as Preferred Shares.

      Securitized by Derivative Contracts.

      You didn’t understand the Derivative Market Meltdown of 2008.

      Lehman’s wasn’t the problem.
      JPM was.



      Ron
      JPM
      littlejohn littlejohn 15 minutes ago
      Traders who played other big names for

      Wednesday could start back in

      here on the cheapies...

      META and MSFT make a lot of money...

      And can spend on Ai - R and D...

      Seems a good money flow watch...

      so we watch..
      MSFT
      hbhmb hbhmb 15 minutes ago
      You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
      Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
      AIAD
      Wrangler1 Wrangler1 18 minutes ago
      Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
      WDLF
      Golfnut3 Golfnut3 19 minutes ago
      Thanks for the input...
      ALYI
      littlejohn littlejohn 26 minutes ago
      Fine idea, put sellers on 28 turned bullish

      on Wednesday with big volume...

      https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

      those are willing share buyers at 28

      if they get exercised with a close on
      SMCI
      trader53 trader53 26 minutes ago
      DPLS 0.0004 - Short Squeeze Soon!


      I'll Alert you of stocks to Buy,
      before the Run happens !

      https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
      ________________________________________________


      https://
      DPLS MFI
      Plato_ Plato_ 28 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
      About us

      VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
      GDVM
      blackcat blackcat 29 minutes ago
      Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
      dinogreeves dinogreeves 33 minutes ago
      SMCI after the report it will get to the right valuation with time.
      SMCI
      dinogreeves dinogreeves 33 minutes ago
      DeepSeek is fake.
      SMCI
      toogoodfella toogoodfella 34 minutes ago
      IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
      YOULL BECOME VERY FAMOUS

      LEHNQ
      trader53 trader53 35 minutes ago
      DPLS 0.0004 - Point of Maximum Financial Opportunity


      I'll Alert you of stocks to Buy,
      before the Run happens !

      https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
      ________________________________________________
      DPLS MFI
      fuagf fuagf 38 minutes ago
      Just hearing of it now on our news. Terrible!!!
      Susie924 Susie924 38 minutes ago
      There wasn’t much to hear but there was definitely a gasp at one point.
      Kool Aid Man Kool Aid Man 40 minutes ago
      Shieldcom's only 'contact' is a mail drop at their registered agent's office --Corporation Trust Center in Delaware. 'In 2012, it was the registered agent address of at least 285,000 separate American and foreign businesses who operate or trade in the United States'
      https://en.wikipedia.org/
      MONI
      jjmentat jjmentat 42 minutes ago
      Did you try Ebay??????
      You know what they say........If you can't get it on Ebay or Walmart.......you're out of luck.......LOL
      Fredddddy Fredddddy 43 minutes ago
      Yes. I had been waiting on a good spot. Unfortunately came down with stomach bug Tuesday. (Thank you children). So I’m just getting back to level. And I missed it. On side lines waiting for entry.
      XMaster2023 XMaster2023 43 minutes ago
      Approval Tomorrow? It’s time!
      NWBO
      blackcat blackcat 44 minutes ago
      Thanks- for some reason it won't load. I'll try it on my other laptop later.
      "Something went wrong. Try reloading".
      Ray_137 Ray_137 48 minutes ago
      April fool's day! Like tons of other predictions.
      COOP
      noradio noradio 53 minutes ago
      Why should a US listed company, that's fully reporting and audited and has disclosed all it needs to disclose. Be halted because Canadian regulators need a vote?
      TWOH
      jeunke22 jeunke22 57 minutes ago
      Here is an interesting article on Apple and GAI confirming your opinion. The market for speed bandwidth, low latency and small form factor of optical engines over fiber connections will take another leap forward.
      https://www.techradar.com/pro/apple-is-the-biggest-winner-of-deepseeks-new-ai-b
      LWLG

      Your Recent History

      NASDAQ
      DYN
      Dyne Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads